A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates

Evgeniia Korotchenko; Y Machado; H Strandt; I Joubert; V Schiessl; R Bauer; M Sarajlic; T Neuper; S Wildner; J Horejs-Hoeck; G Gadermaier; S Scheiblhofer; J Thalhamer; R Weiss

A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates

Evgeniia Korotchenko, Y Machado, H Strandt, I Joubert, V Schiessl, R Bauer, M Sarajlic, T Neuper, S Wildner, J Horejs-Hoeck, G Gadermaier, S Scheiblhofer, J Thalhamer, R Weiss

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Journal	JOURNAL OF IMMUNOLOGY
Volume	202
Issue number	1
Publication status	Published - 2019
Event	AAI annual meeting - San Diego, United States Duration: 9 May 2019 → 13 May 2019

Access to Document

https://www.jimmunol.org/content/202/1_Supplement/70.23

Cite this

Korotchenko, E., Machado, Y., Strandt, H., Joubert, I., Schiessl, V., Bauer, R., Sarajlic, M., Neuper, T., Wildner, S., Horejs-Hoeck, J., Gadermaier, G., Scheiblhofer, S., Thalhamer, J., & Weiss, R. (2019). A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates . JOURNAL OF IMMUNOLOGY , 202(1). https://www.jimmunol.org/content/202/1_Supplement/70.23

Korotchenko, Evgeniia ; Machado, Y ; Strandt, H et al. / A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates . In: JOURNAL OF IMMUNOLOGY 2019 ; Vol. 202, No. 1.

@article{efa1f5c71a7b4b6b9e7bbc8f3c55f629,

title = "A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates ",

author = "Evgeniia Korotchenko and Y Machado and H Strandt and I Joubert and V Schiessl and R Bauer and M Sarajlic and T Neuper and S Wildner and J Horejs-Hoeck and G Gadermaier and S Scheiblhofer and J Thalhamer and R Weiss",

year = "2019",

language = "English",

volume = "202",

journal = "JOURNAL OF IMMUNOLOGY ",

issn = "0022-1767",

number = "1",

note = "AAI annual meeting ; Conference date: 09-05-2019 Through 13-05-2019",

}

Korotchenko, E, Machado, Y, Strandt, H, Joubert, I, Schiessl, V, Bauer, R, Sarajlic, M, Neuper, T, Wildner, S, Horejs-Hoeck, J, Gadermaier, G, Scheiblhofer, S, Thalhamer, J & Weiss, R 2019, 'A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates ', JOURNAL OF IMMUNOLOGY , vol. 202, no. 1. <https://www.jimmunol.org/content/202/1_Supplement/70.23>

A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates . / Korotchenko, Evgeniia; Machado, Y; Strandt, H et al.
In: JOURNAL OF IMMUNOLOGY , Vol. 202, No. 1, 2019.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates

AU - Korotchenko, Evgeniia

AU - Machado, Y

AU - Strandt, H

AU - Joubert, I

AU - Schiessl, V

AU - Bauer, R

AU - Sarajlic, M

AU - Neuper, T

AU - Wildner, S

AU - Horejs-Hoeck, J

AU - Gadermaier, G

AU - Scheiblhofer, S

AU - Thalhamer, J

AU - Weiss, R

PY - 2019

Y1 - 2019

M3 - Abstract (Journal)

SN - 0022-1767

VL - 202

JO - JOURNAL OF IMMUNOLOGY

JF - JOURNAL OF IMMUNOLOGY

IS - 1

T2 - AAI annual meeting

Y2 - 9 May 2019 through 13 May 2019

ER -

Korotchenko E, Machado Y, Strandt H, Joubert I, Schiessl V, Bauer R et al. A novel vaccination platform for epicutaneous allergen-specific immunotherapy based on beta-glucan neoglycoconjugates . JOURNAL OF IMMUNOLOGY . 2019;202(1).